Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Zinc inhibition of monomeric and dimeric proton channels suggests cooperative gating.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (55)
More Search Options
Match
Type
Why
Cardiopulmonary bypass using nafamostat mesilate for patients with infective endocarditis and recent intracranial hemorrhage.
Academic Article
Why?
Ergoloid Mesylates
Concept
Why?
Mesylates
Concept
Why?
A review of resistance patterns and phenotypic changes in gastrointestinal stromal tumors following imatinib mesylate therapy.
Academic Article
Why?
A phase II trial of imatinib mesylate in patients with metastatic pancreatic cancer.
Academic Article
Why?
Imatinib Mesylate
Concept
Why?
Larson, Richard A.
Person
Why?
Accessibility of mid-segment domain IV S6 residues of the voltage-gated Na+ channel to methanethiosulfonate reagents.
Academic Article
Why?
Effect of O6-alkylguanine pretreatment on the sensitivity of human colon tumor cells to the cytotoxic effects of chloroethylating agents.
Academic Article
Why?
Effect of O6-methylguanine on DNA interstrand cross-link formation by chloroethylnitrosoureas and 2-chloroethyl(methylsulfonyl)methanesulfonate.
Academic Article
Why?
Bone marrow with gelatinous transformation associated with residual disease in imatinib mesylate-treated chronic myelogenous leukaemia (CML).
Academic Article
Why?
Combination therapy of imatinib mesylate and interferon-alpha demonstrates minimal activity and significant toxicity in metastatic renal cell carcinoma: results of a single- institution phase II trial.
Academic Article
Why?
Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107.
Academic Article
Why?
Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study.
Academic Article
Why?
Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer.
Academic Article
Why?
Per Page
15
25
50
100
Page
of 4
Next
Prev
Search Criteria
Mesylates
Filter by Type
All
(198)
People
(55)
Research
(140)
Concepts
(3)
_
Click "Why?" to see why an item matched the search.